HORAK IVAN D 4
4 · ENZON PHARMACEUTICALS INC · Filed Sep 24, 2010
Insider Transaction Report
Form 4
HORAK IVAN D
EVP, R&D, Chief Scientific Off
Transactions
- Award
Common Stock
2010-09-22+15,000→ 135,188 total
Footnotes (2)
- [F1]Restricted Stock Units granted by the Issuer pursuant to its 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The Restricted Stock Units shall vest in full on September 22, 2013 and do not have an expiration date; provided, however, that the vesting of 50% of the Restricted Stock Units shall be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer.